Ko Ko

Assistant Professor

Hiroshima University Graduate School of Biomedical and Health Sciences

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Ko Ko is an Assistant Professor at Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan. His research primarily focuses on viral infections, with recent publications addressing topics such as hepatitis E, COVID-19 symptomatology, and the epidemiology of hepatitis B and C. He employs various methodologies, including longitudinal studies and variant screening strategies, to assess disease prevalence and dynamics within populations.

Articles (12)

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Hirohito Imada

Hiroshima University

JAPAN

View details

Junko Tanaka

Prof and Chair/Head of medical School/

Hiroshima University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ko Ko

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Variant-specific Symptoms After COVID-19: A Hospital-based Study in Hiroshima

Epidemiological assessment of hepatitis E virus infection among 1565 pregnant women in Siem Reap, Cambodia using an in‐house double antigen sandwich ELISA

Sequential dynamics of virological and serological changes in the serum of SARS‐CoV‐2 infected patients

A longitudinal study of anti-SARS-CoV-2 antibody seroprevalence in a random sample of the general population in Hiroshima in 2020

Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups

Effect of COVID-19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan

Exercising the Sanger Sequencing Strategy for Variants Screening and Full-Length Genome of SARS-CoV-2 Virus during Alpha, Delta, and Omicron Outbreaks in Hiroshima

Mass Screening of SARS-CoV-2 Variants using Sanger Sequencing Strategy in Hiroshima, Japan

Prevalence and genotype distribution of viral hepatitis B in Cambodia between 1990 and 2020: a systematic review and meta-analysis

Prevalence of Helicobacter pylori infection in the general population evaluated by a resident-register-based epidemiological study

Prevalence of fatty liver and advanced fibrosis by ultrasonography and FibroScan in a general population random sample

Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

Collaborators (2)

Hirohito Imada

Junko Tanaka

Make your next move.